1. Generics Bulletin

Dr Reddy’s Enters OTC Eyecare Space

US Launch Of Pataday Generic Follows Voltaren And Nicorette Rivals

 
• By Akriti Seth

Dr Reddy’s has announced the launch of its OTC versions of Pataday olopatadine solution in the US. The firm’s entry into the OTC eyecare space follows other OTC launches of rivals to Voltaren and Nicorette earlier this year.

OTC
Dr Reddy’s is hoping to reap the benefits of an OTC eyecare presence • Source: Shutterstcok

Marking its entry into the over-the-counter eyecare space, Dr. Reddy's Laboratories Ltd. launched olopatadine hydrochloride 0.2% and 0.1% ophthalmic solution, a generic store-brand equivalent of Novartis’ Pataday OTC eye allergy drops, in the US.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Products